Loading…
Reported covered position: LD/LA,Rep.Ferguson;Transp&InfrastructureCmte
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MODERN MEDICAID ALLIANCE · Firm: THORN RUN PARTNERS
Protect the Medicaid program from funding cuts and policy changes. Track Implementation of H.R. 1 [Public Law No. 119-21].
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MODERN MEDICAID ALLIANCE · Firm: THORN RUN PARTNERS
Protect the Medicaid program from funding cuts and policy changes. Track Implementation of H.R. 1 [Public Law No. 119-21].
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2026 · third_quarter · Q3
FY27 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2026 · third_quarter · Q3
Source: Senate LDA
| PATIENT SERVICES INCORPORATED (PSI) |
| 34 |
| 2012–2020 |
| GLAXOSMITHKLINE LLC | 33 | 2017–2024 |
| THE BIOSIMILARS FORUM | 33 | 2019–2026 |
| PARTNERSHIP FOR PART D ACCESS (INFORMAL COALITION) | 32 | 2014–2021 |
| ROPER ST. FRANCIS HEALTHCARE | 23 | 2022–2026 |
| MCALLISTER & QUINN ON BEHALF OF VILLANOVA UNIVERSITY | 22 | 2017–2021 |
| AMYLYX | 21 | 2021–2026 |
| VILLANOVA UNIVERSITY | 19 | 2022–2026 |
| NATIONAL COUNCIL FOR MENTAL WELLBEING | 18 | 2013–2018 |
| LUNDBECK LLC | 17 | 2012–2016 |
| ELI LILLY AND COMPANY | 14 | 2021–2023 |
| Liquidia Technologies, Inc. | 14 | 2023–2026 |
| ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) | 13 | 2023–2026 |
| Arbor Pharmaceuticals, LLC | 13 | 2015–2017 |
| MOYER FOUNDATION | 13 | 2014–2017 |
| ALLIANCE FOR DRONE INNOVATION (INFORMAL) | 12 | 2018–2020 |
| AGRI-SERVICES AGENCY | 8 | 2013–2014 |
| AMERICAN PSYCHIATRIC ASSOCIATION | 8 | 2017–2019 |
| MODERN MEDICAID ALLIANCE | 8 | 2025–2026 |
| MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY | 7 | 2012–2013 |
| NATIONAL HOME INFUSION ASSOCIATION | 7 | 2025–2026 |
| EXPRESS SCRIPTS INC | 6 | 2017–2018 |
| GREENBERRY INDUSTRIAL | 6 | 2013 |
| INSPIRION PHARMACEUTICALS, LLC | 6 | 2014–2015 |
| VISITING NURSE SERVICE OF NEW YORK | 6 | 2013–2014 |
| ALORA PHARMACEUTICALS, LLC | 5 | 2025–2026 |
| AMERICAN SOCIETY OF CONSULTANT PHARMACISTS (ASCP) | 5 | 2024 |
| TELEHEALTH ACCESS FOR BEHAVIORAL HEALTH | 5 | 2020–2021 |
| UNITE US | 5 | 2025 |
| HACKENSACK MERIDIAN HEALTH | 4 | 2015–2016 |
| IMPRIVATA, INC. | 4 | 2016 |
| PHYSICIAN-LED HEALTHCARE FOR AMERICA | 4 | 2026 |
| CHEMBIO DIAGNOSTICS, INC. | 3 | 2013 |
| ELECTROCHEMICAL OXYGEN CONCEPTS, INC. (EO2 CONCEPTS) | 3 | 2012 |
| ALLERGAN, INC. | 2 | 2012 |
| ENCORE GLOBAL INVESTMENT MANAGEMENT, LLC | 2 | 2013 |
| ROCHE DIAGNOSTICS | 2 | 2012 |
| SIDECAR | 2 | 2014 |
| US NATURALS | 2 | 2015 |
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Physician Led and Rural Access to Quality Care Act
Client: PHYSICIAN-LED HEALTHCARE FOR AMERICA · Firm: THORN RUN PARTNERS
Educating about and expanding the ability for physician-owned hospitals to operate. H.R.2191 - Physician Led and Rural Access to Quality Care Act.
Physician Led and Rural Access to Quality Care Act
Client: PHYSICIAN-LED HEALTHCARE FOR AMERICA · Firm: THORN RUN PARTNERS
Educating about and expanding the ability for physician-owned hospitals to operate. H.R.2191 - Physician Led and Rural Access to Quality Care Act.
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Biosimilar Red Tape Elimination Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Biosimilar Red Tape Elimination Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Biosimilar Red Tape Elimination Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: AMYLYX · Firm: THORN RUN PARTNERS
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: AMYLYX · Firm: THORN RUN PARTNERS
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Expedited Access to Biosimilars Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Expedited Access to Biosimilars Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Biosimilar Red Tape Elimination Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Biosimilar Red Tape Elimination Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.2679 - Pharmacy Benefits Manager Accountability Act. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation. H.R.3935 - FAA Reauthorization Act of 2024. H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation. H.R.3935 - FAA Reauthorization Act of 2024.
Health care and Judiciary issues. S.2220 / H.R. 4370 - The PREVAIL Act.
Health care and Judiciary issues related to FDA approval. S.2220 / H.R. 4370 - The PREVAIL Act.
Health care and Judiciary issues. S.2220 / H.R. 4370 - The PREVAIL Act.
Health care and Judiciary issues related to FDA approval. S.2220 / H.R. 4370 - The PREVAIL Act.
D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation. H.R.3935 - FAA Reauthorization Act of 2024. H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation. H.R.3935 - FAA Reauthorization Act of 2024. H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation. H.R.3935 - FAA Reauthorization Act of 2024.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation.
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development. S.2220 - PREVAIL Act.
Health care and Judiciary issues. S.2220 / H.R. 4370 - The PREVAIL Act.
Health care and Judiciary issues related to FDA approval. S.2220 / H.R. 4370 - The PREVAIL Act.
Health care and Judiciary issues related to FDA approval. S.2220 / H.R. 4370 - The PREVAIL Act.
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development. S.2220 - PREVAIL Act.
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development. S.2220 - PREVAIL Act.
Health care and Judiciary issues. S.2220 / H.R. 4370 - The PREVAIL Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.2679 - Pharmacy Benefits Manager Accountability Act. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: ALKERMES, INC. · Firm: THORN RUN PARTNERS
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Pharmacy Benefits Manager Accountability Act
Client: THE BIOSIMILARS FORUM · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act.
Health care and Judiciary issues. S.2220 / H.R. 4370 - The PREVAIL Act.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. S.3258 - ALS Better Care Act. H.R.5663 - To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation.
Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023
Client: NATIONAL FOOTBALL LEAGUE · Firm: THORN RUN PARTNERS
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Drone safety, S.1631 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023. Issues related to the College Athletes Bill of Rights legislation.
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2026 · third_quarter · Q3
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHYSICIAN-LED HEALTHCARE FOR AMERICA via THORN RUN PARTNERS
2026 · third_quarter · Q3
Educating about and expanding the ability for physician-owned hospitals to operate. H.R.2191 - Physician Led and Rural Access to Quality Care Act.
Educating about and expanding the ability for physician-owned hospitals to operate. H.R.2191 - Physician Led and Rural Access to Quality Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2026 · third_quarter · Q3
Protect the Medicaid program from funding cuts and policy changes. Track Implementation of H.R. 1 [Public Law No. 119-21].
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
CJS Appropriations.
Health care and Judiciary issues related to FDA approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients. Issues related to Post-Bariatric Hypoglycemia (PBH).
H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · third_quarter · Q3
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Health care and Judiciary issues related to FDA approval.
CJS Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Labor-H Appropriations.
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · second_quarter · Q2
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALKERMES, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2026 · second_quarter · Q2
FY27 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2026 · second_quarter · Q2
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHYSICIAN-LED HEALTHCARE FOR AMERICA via THORN RUN PARTNERS
2026 · second_quarter · Q2
Educating about and expanding the ability for physician-owned hospitals to operate.
Educating about and expanding the ability for physician-owned hospitals to operate.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2026 · second_quarter · Q2
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2026 · second_quarter · Q2
Protect the Medicaid program from funding cuts and policy changes. Track Implementation of H.R. 1 [Public Law No. 119-21].
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2026 · first_quarter · Q1
FY27 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2026 · first_quarter · Q1
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2026 · first_quarter · Q1
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHYSICIAN-LED HEALTHCARE FOR AMERICA via THORN RUN PARTNERS
2026 · first_quarter · Q1
Educating about and expanding the ability for physician-owned hospitals to operate.
Educating about and expanding the ability for physician-owned hospitals to operate.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2026 · first_quarter · Q1
Protect the Medicaid program from funding cuts and policy changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Health care and Judiciary issues related to FDA approval.
CJS Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Labor-H Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · first_quarter · Q1
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
PHYSICIAN-LED HEALTHCARE FOR AMERICA via THORN RUN PARTNERS
2026 · first_quarter · RR
Educating about and expanding the ability for physician-owned hospitals to operate.
Educating about and expanding the ability for physician-owned hospitals to operate.
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Health care and Judiciary issues related to FDA approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Labor-H Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
FY26 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Protect the Medicaid program from funding cuts and policy changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
UNITE US via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Federal health policy and social care programs.
Federal health policy and social care programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2025 · third_quarter · Q3
FY26 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITE US via THORN RUN PARTNERS
2025 · third_quarter · Q3
Federal health policy and social care programs.
Federal health policy and social care programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2025 · third_quarter · Q3
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2025 · third_quarter · Q3
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Medicare and Medicaid coverage for home infusion professional services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2025 · third_quarter · Q3
Protect the Medicaid program from funding cuts and policy changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Health care and Judiciary issues related to FDA approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Labor-H Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2025 · third_quarter · Q3
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling. H.R.4466 - CIRCLE Act.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · second_quarter · Q2
FAA Reauthorization. Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2025 · second_quarter · Q2
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
ALKERMES, INC. via THORN RUN PARTNERS
2025 · second_quarter · Q2
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2025 · second_quarter · Q2
FY26 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · second_quarter · Q2
Medicare and Medicaid coverage for home infusion professional services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2025 · second_quarter · Q2
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation.
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2025 · second_quarter · Q2
Protect the Medicaid program from funding cuts and policy changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2025 · second_quarter · Q2
Health care and Judiciary issues related to FDA approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2025 · second_quarter · Q2
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Labor-H Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2025 · second_quarter · Q2
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITE US via THORN RUN PARTNERS
2025 · second_quarter · Q2
Federal health policy and social care programs.
Federal health policy and social care programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2025 · second_quarter · Q2
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VILLANOVA UNIVERSITY via THORN RUN PARTNERS
2025 · first_quarter · Q1
FY26 House/Senate Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITE US via THORN RUN PARTNERS
2025 · first_quarter · Q1
Federal health policy and social care programs.
Federal health policy and social care programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BIOSIMILARS FORUM via THORN RUN PARTNERS
2025 · first_quarter · Q1
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation.
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ROPER ST. FRANCIS HEALTHCARE via THORN RUN PARTNERS
2025 · first_quarter · Q1
Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · first_quarter · Q1
FAA Reauthorization. Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · first_quarter · Q1
Medicare and Medicaid coverage for home infusion professional services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL FOOTBALL LEAGUE via THORN RUN PARTNERS
2025 · first_quarter · Q1
Legislative and regulatory policy issues affecting the professional sports industry, such as player health and safety, antitrust, intellectual property, and sports betting. Issues related to the College Athletes Bill of Rights legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIQUIDIA TECHNOLOGIES, INC. via THORN RUN PARTNERS
2025 · first_quarter · Q1
Health care and Judiciary issues related to FDA approval.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERDIGITAL, INC. via THORN RUN PARTNERS
2025 · first_quarter · Q1
Legislation relating to the impact of patent reform on IP protections. Issues relating to patent reform. Issues relating to trade. Issues relating to 5G and 6G development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.
Labor-H Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2025 · first_quarter · Q1
Protect the Medicaid program from funding cuts and policy changes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) via THORN RUN PARTNERS
2025 · first_quarter · Q1
Issues related to the 340B drug discount program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via THORN RUN PARTNERS
2025 · first_quarter · Q1
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED DRAINAGE SYSTEMS via THORN RUN PARTNERS
2025 · first_quarter · Q1
Issues related to transportation reauthorization. Issues related to competitive bidding. General issues relating to infrastructure. Issues related to recycling.
Filing targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
MODERN MEDICAID ALLIANCE via THORN RUN PARTNERS
2025 · first_quarter · RR
Protect the Medicaid program from funding cuts and policy changes.
UNITE US via THORN RUN PARTNERS
2025 · first_quarter · RR
Federal health policy and social care programs.
Federal health policy and social care programs.